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Background
The molecular mechanisms associated with the acquisi-
tion of a metastatic phenotype by melanoma cells are
not very well understood. Therefore, the identification
of molecular determinants involved in the metastatic
switch that may either cause or contribute to the aggres-
siveness of melanoma is of primary relevance.
We had previously identified neuropilin-1 (NRP-1), a
co-receptor of the vascular endothelial growth factor-A
(VEGF-A), as an important determinant of melanoma
aggressiveness, in clones of the human melanoma cell line
M14, expressing or not NRP-1 [1,2]. We demonstrated
that even though the simultaneous presence of both
VEGFR-2 and NRP-1 potentiates VEGF-A secretion and
the aggressiveness of melanoma cells, NRP-1 is by itself
able to promote cell invasion [1].
During melanoma progression, tumour cells show
increased adhesiveness to the vascular wall, invade the
extracellular matrix (ECM) and frequently form functional
channels similar to vascular vessels (vasculogenic mimicry)
[3]. In the present study we analysed the mechanisms
responsible for the aggressive phenotype of NRP-1 expres-
sing melanoma cells.
Materials and methods
Melanoma aggressiveness was evaluated in vitro as cell
ability to migrate through an ECM layer in Boyden
chambers and to form tubule-like structures on matrigel
gels. Pre-incubation of the cells with specific blocking
antibodies allowed the identification of specific integrins
and other molecules relevant to these processes. The
results obtained by anti-integrin antibodies, showing the
involvement of avb5 integrin in the aggressiveness of
melanoma cells expressing NRP-1, were confirmed by
ITGB5 gene silencing and by the use of cilengitide, a
potent inhibitor of aν integrins activation.
Results
The expression of avb5 integrin was found to be twice
higher in NRP-1 expressing melanoma cells than in the
low-invasive NRP-1 negative control. Its blockage
resulted in a significant decrease of the ability of NRP-1
expressing cells to invade ECM and to form tubule-like
structures on matrigel. Cilengitide and ITGB5 silencing
reduced ECM invasion and vasculogenic mimicry.
Moreover, cilengitide down-modulated the secretion of
VEGF-A and metalloproteinase-9 (MMP-9). Finally,
melanoma cells expressing NRP1, but lacking other
VEGF-A or PlGF receptors (VEGFR-1 and VEGFR-2),
specifically responded to PlGF in a chemotactic assay.
Conclusions
In conclusion, we identified novel mechanisms that
modulate melanoma aggressiveness involving NRP-1,
aνb5 integrin and PlGF, which might be considered as
new targets of therapeutic strategies to inhibit the meta-
static disease.
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